J&J buys medical device maker Shockwave Medical for $13.1 billion
[ad_1]
American corporation Johnson & Johnson (J&J) announced on the purchase of Shockwave Medical, a company specializing in the production of devices for the treatment of cardiovascular diseases. The deal will be worth $13.1 billion. J&J will pay Shockwave shareholders $335 in cash per share, a premium of almost 5% to the stock’s closing price on Thursday and 17% to the price at the end of March, when US media first reported on the deal. possible deal.
Shockwave devices are used by about 400 thousand people in different countries. The company’s revenue grew 50% last year to $730 million. J&J said the acquisition of Shockwave will help it grow its MedTech business and expand its range of devices for the treatment of cardiovascular diseases.
J&J is showing increased activity in the MedTech market. In 2022 it will cost $16.6 billion bought manufacturer of high-tech implants Abiomed, and last year acquired Laminar, a company that produces devices to reduce the risk of stroke in patients with certain cardiovascular diseases, for $400 million.
[ad_2]
Source link
